2024-03-14 08:00
Several new commercial agreements signed and evidence that DiviTum® TKa significantly improves clinical routines in the USA.
2023-11-28 08:00
Continued sales growth and several commercial agreements signed!
2023-09-06 08:00
Higher sales and commercial milestones achieved in the USA
2023-06-21 08:00
Significant events during the first three quarters Significant events during the fourth quarter Significant events after the end of the period Webcast: When: 21 June 2023, 3 PM to 4 PM CET Where: registration via lyyti: https://www.lyyti.in/Q4_Earnings_Call...
2023-03-16 08:00
DiviTum® TKa ready for clinical use in the US
2022-12-15 08:00
Successful capital acquisition paves the way for launch in the USA
2022-08-31 08:00
Significant events during the first quarter · Results with DiviTum®TKa at ASCO · DiviTum®TKa highlighted at ASCO in an oral presentation · Biovica’s CFO will terminate employment in December 2022 · ...
2022-06-16 08:00
Significant events during the fourth quarter Significant events after the end of the period Audiocast: When: 16 June 2022 at 15.00 CET Where: https://tv.streamfabriken.com/biovica-international-q4-2021-2022 Phone numbers: SE: +46856642692, DK: +4578723252...
2022-03-15 08:00
Significant events during the third quarter Significant events after the end of the period Audiocast: When: 15 March 2022 at 3 PM CET Where: https://tv.streamfabriken.com/biovica-international-q3-2021-2022 Phone numbers: SE: +46850558356, DK: +4582333194...
2021-12-01 07:30
Significant events during the second quarter Significant events after the end of the period Audiocast: When: 1 December 2021 at 3 PM CET Where: https://tv.streamfabriken.com/biovica-international-q2-2021-2022 Phone numbers: SE: +46850558350, DK: +4578150109...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects